Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877708 · ClinicalTrials.gov registry record
Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
A clinical trial of E Coli Infections, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT00877708 is a study of E Coli Infections that has completed, run by University of Pittsburgh. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00877708, a study of E Coli Infections, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in hospitals or nursing homes and determine their clinical outcomes. The specific aims of this study are to: 1. Review whether cephalosporin-resistant E. coli infections are hospital-acquired, healthcare-associated or community-associated. 2. Determine the clinical outcome of the patients according to the antibiotics given.
Conditions Studied
Study Locations (1)
Pennsylvania
- UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-03 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00877708
The ClinicalTrials.gov registry entry for NCT00877708 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with E Coli Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00877708 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00877708 about?
NCT00877708 is a clinical study titled "Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol". The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in hospitals or nursing homes and determine their clinical outcomes. The specific aims of this study ar...
What is the current status of trial NCT00877708?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2009-03. Estimated completion is 2017-12.
What conditions does trial NCT00877708 study?
This clinical trial studies the following conditions: E Coli Infections.
Who is sponsoring clinical trial NCT00877708?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00877708 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for E Coli Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant
RECRUITING · Phase 1
-
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.